Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
13%(1 trials)

Phase Distribution

Ph not_applicable
7
64%
Ph phase_4
3
27%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (30.0%)
N/A7 (70.0%)

Trials by Status

unknown218%
completed873%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11